What is NEXT-ChemX Corporation?
NEXT-ChemX Corporation owns ion targeting membrane extraction technology in the United States.
CHMX · Verdict
Moderate reward · high risk
CHMX's standout is volatility; cash flow and balance sheet weigh on the picture.
Based on 88% data coverage
CHMX · Verdict
Above average
Weak vs peers
Current ratio 0.15
-4607% return on equity
Earnings +0.6% CAGR
Model-based scoring. For information only — not financial advice.
NEXT-ChemX Corporation owns ion targeting membrane extraction technology in the United States. The company's technology mimics nature biophysical processes enabling the technology to extract ions from a liquid solution at ambient temperatures and pressures. The company is listed on the PINK in USA, operating in the Industrials sector, with a market capitalisation of 316.87K.
The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are high — this profile reflects meaningful downside exposure.
For informational purposes only. Not financial advice.